O. Kleifeld
Nature Reviews. Cancer · 2006
A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 2 researchers here, as inferred from the citation graph.
Whom O. Kleifeld trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts O. Kleifeld overall
Papers from O. Kleifeld's perspective
Ordered by how strongly the researchers O. Kleifeld trusts endorse each paper. Same corpus, a different order for every researcher.
- New functions for the matrix metalloproteinases in cancer progression (Nature Reviews. Cancer)
- Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis (Nature Cell Biology)
- Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. (Science)
- A phase 2 study of bortezomib in relapsed, refractory myeloma. (New England Journal of Medicine)
- Breast cancer metastasis: markers and models (Nature Reviews. Cancer)
- Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. (Journal of Clinical Investigation)
- Failing the public health--rofecoxib, Merck, and the FDA. (New England Journal of Medicine)
- Drug discovery: a historical perspective. (Science)
- A multigenic program mediating breast cancer metastasis to bone. (Cancer Cell)
- Matrix Metalloproteinase Activity Inactivates the CXC Chemokine Stromal Cell-derived Factor-1* (Journal of Biological Chemistry)
Their papers
- Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy (2006) — 1,111 citations